Skip to main content

Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.

Citation
Knapp, M., et al. “Vascular Endothelial Dysfunction, A Major Mediator In Diabetic Cardiomyopathy.”. Acta Pharmacologica Sinica, pp. 1-8.
Center University of Chicago
Author Maura Knapp, Xin Tu, Rongxue Wu
Keywords cardiomyopathy, diabetes, diabetic cardiovascular complications, endothelium, Heart failure, Metabolism, vascular
Abstract

Diabetes mellitus is currently a major public health problem. A common complication of diabetes is cardiac dysfunction, which is recognized as a microvascular disease that leads to morbidity and mortality in diabetic patients. While ischemic events are commonly observed in diabetic patients, the risk for developing heart failure is also increased, independent of the severity of coronary artery disease and hypertension. This diabetes-associated clinical entity is considered a distinct disease process referred to as "diabetic cardiomyopathy". However, it is not clear how diabetes promotes cardiac dysfunction. Vascular endothelial dysfunction is thought to be one of the key risk factors. The impact of diabetes on the endothelium involves several alterations, including hyperglycemia, fatty acid oxidation, reduced nitric oxide (NO), oxidative stress, inflammatory activation, and altered barrier function. The current review provides an update on mechanisms that specifically target endothelial dysfunction, which may lead to diabetic cardiomyopathy.

Year of Publication
2019
Journal
Acta pharmacologica Sinica
Volume
40
Issue
1
Number of Pages
1-8
Date Published
01/2019
ISSN Number
1745-7254
DOI
10.1038/s41401-018-0042-6
Alternate Journal
Acta Pharmacol. Sin.
PMID
29867137
PMCID
PMC6318313
Download citation